Trans-Atlantic Inter-Society Consensus II C and D iliac lesions can be treated by endovascular and hybrid approach: a

Maurizio Taurino1, Francesca Persiani, Cristiano Fantozzi

  • 11Department of Vascular Surgery, Sant'Andrea Hospital, University of Rome-"La Sapienza", Rome, Italy.

Insights

Endovascular and hybrid treatments are effective for severe aortoiliac lesions (TASC II C-D), challenging traditional guidelines. Individual lesion analysis is crucial for successful outcomes in complex cases.

Area of Science:

  • Vascular Surgery
  • Endovascular Interventions
  • Aortoiliac Disease Management

Background:

  • Trans-Atlantic Inter-Society Consensus (TASC) II guidelines traditionally recommend open surgical repair for TASC II type C and D aortoiliac lesions.
  • Complex aortoiliac occlusive disease presents significant challenges for revascularization.
  • Evaluating less invasive treatment options is critical for improving patient outcomes.

Purpose of the Study:

  • To assess the long-term efficacy of endovascular and hybrid revascularization for TASC II type C and D aortoiliac lesions.
  • To emphasize the importance of individualized lesion assessment over strict adherence to TASC II guidelines.
  • To determine the safety and patency rates of these advanced treatment modalities.

Main Methods:

  • A retrospective analysis of 50 patients with TASC II C and D aortoiliac lesions treated between January 2008 and December 2012.
  • Patients underwent either endovascular (76%) or hybrid (24%) treatment.
  • A comprehensive postoperative surveillance program was implemented, with regular follow-up intervals.

Main Results:

  • 100% technical success rate was achieved in all treated patients.
  • Low postoperative complication rate of 4% was observed.
  • Excellent long-term patency rates: primary patency of 86.6% at 3 years and secondary patency of 97.7% at 3 years.
  • High survival (91.1% at 3 years) and 100% limb salvage rates were reported.

Conclusions:

  • Endovascular or hybrid treatment represents a viable and effective alternative for TASC II type C and D aortoiliac lesions, contrary to conventional guidelines.
  • Hybrid approaches can significantly improve distal perfusion (runoff), which is vital for treating multilevel disease.
  • Individualized assessment of each iliac axis is paramount for selecting the optimal treatment strategy in complex cases.
Abstract

Related Concept Videos

Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
478
Varicose Veins II: Diagnostic Studies and Interprofessional Care01:26

Varicose Veins II: Diagnostic Studies and Interprofessional Care

Varicose veins, or varicosities, develop when the valves in the veins, which control blood flow, weaken or damage. It causes blood to pool and the veins to enlarge. Understanding the clinical manifestations, diagnostic approaches, and management options for varicose veins is crucial for effective treatment and relief.Clinical manifestationsClinical manifestations of varicose veins include a heavy, achy feeling or pain after prolonged standing or sitting. This discomfort can often be relieved by...
325
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
659